Results 181 to 190 of about 4,795,723 (322)

Once daily intravenous busulfan as part of a busulfan/cyclophosphamide conditioning regimen for allogeneic hematopoietic stem cell transplantation [PDF]

, 2004
Mihaela Mates, H. Michalska, Wanda Hasegawa, Thomas Kiss, Andrew Daly, David Loach, Hans A. Messner, Jeffrey H. Lipton   +7 more
openalex   +1 more source

Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee.

Biology of Blood and Marrow Transplantation, 2016
J. Palmer, J. McCune, M. Perales, D. Marks, J. Bubalo, M. Mohty, J. Wingard, A. Paci, Moustapha Hassan, C. Bredeson, J. Pidala, N. Shah, P. Shaughnessy, N. Majhail, J. Schriber, B. Savani, P. Carpenter   +16 more
semanticscholar   +1 more source

Cardiovascular outcomes in patients receiving myeloablative vs. reduced intensity conditioning prior to allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia

, 2020
Majd El‐Harasis, Mehrdad Hefazi, Raghav Julakanti, William J. Hogan, Mark R. Litzow, Mrinal M. Patnaik, Joerg Herrmann   +6 more
openalex   +2 more sources

Allogeneic Hematopoietic Stem Cell Transplantation (SCT) Using Fludarabine/Treosulfan Conditioning Regimen Compared With Busulfan-Based Myeloablative And Reduced-Intensity Conditioning In Patients With AML And MDS; Relative Outcomes Depend On Disease Status At SCT [PDF]

, 2010
Avichai Shimoni, Noga Shem‐Tov, Avital Rand, Yulia Volchek, Ronit Yerushalmi, Izhar Hardan, Arnon Nagler   +6 more
openalex   +1 more source

Reduced-Intensity Transplant Conditioning Procedure [PDF]

, 2020
openaire   +1 more source

Phase 1 results of ZUMA-1: A multicenter study of KTE-C19 anti-CD19 CAR T cell therapy in refractory aggressive lymphoma [PDF]

, 2017
Bartlett, Nancy L, et al,, Ghobadi, Armin   +2 more
core   +2 more sources

Overall survival, conditioning, and MRD in MORPHO. [PDF]

Blood Adv
Gui G, Hourigan CS.
europepmc   +1 more source

Transplantation conditioning regimens: can we say it better?

Biology of Blood and Marrow Transplantation, 2009
H. Deeg
semanticscholar   +1 more source

Cotransplantation of Mesenchymal Stem Cells Might Prevent Death from Graft-versus-Host Disease (GVHD) without Abrogating Graft-versus-Tumor Effects after HLA-Mismatched Allogeneic Transplantation following Nonmyeloablative Conditioning

, 2010
Frédéric Baron, Chantal Lechanteur, Évelyne Willems, France Bruck, Étienne Baudoux, Laurence Seidel, Jean-François Vanbellinghen, Kaoutar Hafraoui, Marie Lejeune, André Gothot, Georges Fillet, Yves Béguin   +11 more
openalex   +1 more source

Persistence of host-type hematopoiesis after allogeneic bone marrow transplantation for leukemia is significantly related to the recipient's age and/or the conditioning regimen, but it is not associated with an increased risk of relapse [PDF]

, 1994
JE van Leeuwen, MJ van Tol, AM Joosten, JT Wijnen, Paul E. Verweij, PM Khan, JM Vossen   +6 more
openalex   +1 more source